Regular paper
Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304

https://doi.org/10.1016/0014-2999(95)00265-MGet rights and content

Abstract

We studied the possibility that presynaptic inhibition of transmitter release from postganglionic sympathetic neurons contributes to the overall reduction of sympathetic tone produced by moxonidine, rilmenidine and 5-bromo-6-(2-imidazolin-2-ylamino)-quinoxaline tartrate (UK 14304). In pithed rabbits without electric stimulation, moxonidine, rilmenidine and UK 14304 caused a long-lasting, > 10 min, increase in arterial pressure. Heart rate was not changed. In pithed rabbits in which sympathetic tone was created by electric stimulation through the pithing rod (2 Hz), the same doses of moxonidine, rilmenidine and UK 14304 caused only a brief, < 10 min, blood pressure rise. Heart rate was decreased, as were the plasma concentrations of noradrenaline and adrenaline. Dose-response curves for the effects on the plasma noradrenaline concentration (stimulated pithed rabbits) were compared with previously obtained dose-response curves for depression of renal sympathetic nerve activity (conscious rabbits). For each drug, the curve describing peripheral presynaptic inhibition and the curve describing central sympathoinhibition were very similar. Both the power and the dose dependence of the peripheral inhibitory effect support its contribution to the overall decrease in sympathetic tone produced by clonidine-like drugs in intact animals. The peripheral effect in all likelihood consists in activation of presynaptic α2-autoreceptors. The agreement of the dose-response curves for the peripheral and for the central effect supports the view that the central effect, like the peripheral one, is mediated through α2-adrenoceptors.

References (58)

  • B.I. Armah et al.

    General pharmacology of the novel centrally acting antihypertensive agent moxonidine

    Arzneim.-Forsch./Drug Res.

    (1988)
  • C. Bohmann et al.

    Effects of imidazolines on noradrenaline release in rat isolated kidney

    Naunyn-Schmied. Arch. Pharmacol.

    (1994)
  • P. Bousquet et al.

    Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines

    J. Pharmacol. Exp. Ther.

    (1984)
  • M.J. Brown et al.

    Evidence for a peripheral component in the sympatholytic effect of clonidine in rats

    Br. J. Pharmacol.

    (1984)
  • P. Chrisp et al.

    Moxonidine

    Drugs

    (1992)
  • A. De Jonge et al.

    Participation of cardiac presynaptic α2-adrenoceptors in the bradycardiac effects of clonidine and analogues

    Naunyn-Schmied. Arch. Pharmacol.

    (1981)
  • H. Ensinger et al.

    Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits

    J. Pharmacol. Exp. Ther.

    (1985)
  • P.R. Ernsberger et al.

    A second generation of centrally acting antihypertensive agents act on putative I1-imidazoline receptors

    J. Cardiovasc. Pharmacol.

    (1992)
  • P. Ernsberger et al.

    Moxonidine: a second-generation central antihypertensive agent

    Cardiovasc. Drug Rev.

    (1993)
  • J. Feldman et al.

    Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit

    Br. J. Pharmacol.

    (1990)
  • M. Garty et al.

    Effects of clonidine on renal sympathetic nerve activity and norepinephrine spillover

    J. Pharmacol. Exp. Ther.

    (1990)
  • M. Göthert et al.

    Involvement of presynaptic imidazoline receptors in the α2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives

    Naunyn-Schmied. Arch. Pharmacol.

    (1991)
  • E. Grossman et al.

    Evidence for functional α2-adrenoceptors on vascular sympathetic nerve endings in the human forearm

    Circ. Res.

    (1991)
  • G. Haeusler

    Studies on the possible contribution of a peripheral presynaptic action of clonidine and dopamine to their vascular effects under in vivo conditions

    Naunyn-Schmied. Arch. Pharmacol.

    (1976)
  • J.P. Hieble et al.

    Mediation of the hypotensive action of systemic clonidine in the rat by α2-adrenoceptors

    Br. J. Pharmacol.

    (1993)
  • W. Kobinger

    Über den Wirkmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur

    Naunyn-Schmied. Arch. Pharmakol. Exp. Pathol.

    (1967)
  • W. Kobinger

    Drugs as tools in research on adrenoceptors

    Naunyn-Schmied. Arch. Pharmacol.

    (1986)
  • W. Kobinger et al.

    Centrally acting drugs (clonidine, methyldopa, guanfacine)

  • S.Z. Langer

    Presynaptic regulation of the release of catecholamines

    Pharmacol. Rev.

    (1981)
  • Cited by (0)

    View full text